EDAP TMS S.A. (EDAP) Reports Q3 EPS of EUR0.19
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- Fed: Nine Of 18 FOMC Participants Pencil In 2026 Rate Hike
- Delta Air Lines (DAL) Raises Quarterly Dividend 14.7% to $0.2150; 1% Yield
- Oil rises 1% on US-Iran deal doubts; IEA warns of supply glut
EDAP Reports Third Quarter 2015 Financial Results and Operational Update
November 18, 2015 5:45 PM ESTObtained FDA clearance for Ablatherm® HIFU in November Received first four U.S. orders for Ablatherm Record nine-month net sales of 20.5 million HIFU treatment-driven revenue increased 41% year-over-year Strong backlog for both lithotripsy and HIFU divisions entering Q4 First Focal One® Device sold in South America
LYON, France, Nov. 18, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced financial results for the third quarter ended September 30, 2015 and provided an update on recent strategic and operational highlights.
Marc... More
